Jensen, Stella
Roberti, Roberta
Napolitano, Alessandro
Bosco, Vincenzo
Russo, Emilio https://orcid.org/0000-0002-1279-8123
Iudice, Alfonso
Article History
Received: 30 October 2024
Accepted: 10 November 2025
First Online: 5 January 2026
Declarations
: We confirm that manuscript complies with all instructions to authors.
: We confirm that authorship requirements have been met and the final manuscript was approved by all authors.
: We confirm that this manuscript has not been published elsewhere and is not under consideration by another journal.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: We declare the following Conflicts of Interest: Jensen Stella: Nothing to declare. Roberti Roberta: Consultant for Eisai Italy. Napolitano Alessandro: Nothing to declare. Bosco Vincenzo: Nothing to declare. Russo Emilio: Speaker fees, advisory participation, consultancy, fundings by Angelini Pharma, Ethypharm, Eisai, Jazz Pharmaceuticals, Kolfarma, UCB Pharma. Iudice Alfonso: Consultancy fees from Angelini, Bayer, Eisai. We declare that no checklists were needed regarding the content of this manuscript.